Pain and Anesthesia Market

BioNationLogin

Email

Password

I've forgotten my password!
Create an account here!

Therapeutic Areas

Competencies

Services

Devices

Pain and Anesthesia

Painand Anesthesia Business News

gw pharmaceuticals release: health canada grants full approval of sativex(r) for the treatment of sp ... Aug 31 2010
ortho-mcneil-janssen pharmaceuticals, inc.'s pivotal phase 3 study compares tapentadol extended rele ... Aug 30 2010
afferent pharmaceuticals announces data supporting potential utility of proprietary p2x3 antagonists ... Aug 25 2010
nutra pharma corp. (nphc) begins drug registration process in india for nyloxin - a treatment for mo ... Aug 19 2010
simcere pharmaceutical group announces sfda approval to manufacture and market palonosetron in china ... Aug 12 2010
trigemina reports positive results with its lead compound ti-001 in a phase iia clinical trial for c ... Aug 11 2010
endo pharmaceuticals agrees to acquire penwest pharmaceuticals and submits nda for new formulation o ... Aug 9 2010

Pain and Anesthesia Jobs

Find an open position today!

NuPathe closes USD 30 Million Financing

NuPathe completes USD 30 million financing as it announces positive phase I trials for NP-101. by Pierre-Philippe Luyet, PhD , 28/07/2008

Following the Fibromyalgia Treatment Lyrica Leads

by Ronald Maldonado Rodriguez, PhD MSc , 18/04/2008

Pain Releasers Transdel’s Ketotransdel and Anesiva’s Adlea into Phase 3 Clinical Programs

Transdel Pharmaceuticals and Anesiva initiate Phase 3 clinical trials evaluating their respective products Ketotransdel and Adlea.11/04/2008

Eisai’s Aloxi Injection receives FDA Approval while BioDelivery Sciences Seeks FDA Approval to Market BEMA Fentanyl

07/04/2008

EUR 8 M Upfront Payment For Newron To Purchase Hunter-Fleming

18/02/2008

Painand Anesthesia Headlines

Painand Anesthesia Partnerships